Financials
- Market Capitalization 477.95 M
- Employee 67
- Founded 2012
- CEO N/A
- Website www.prothena.com
- Headquarter Ireland
- FIGI UNKNOWN
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.11
Rapporto prezzo/fatturato
21.58
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2931 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.84 USD | -7.89% | -11.38% | +25.86% | +352.71% | 466.05 M USD | ||
| 2935 | EVMN Evommune, Inc. Common Stock | 13.42 USD | -0.07% | -5.16% | +20.79% | -22.52% | 487.04 M USD | ||
| 2951 | RLMD Relmada Therapeutics, Inc. - Common Stock | 4.41 USD | -2.43% | -4.75% | -15.68% | +431.33% | 470.41 M USD | ||
| 2953 | RZLT Rezolute, Inc. - Common Stock | 4.74 USD | -4.82% | -5.58% | -3.85% | -34.98% | 456.43 M USD |